Patents by Inventor Lindsey James

Lindsey James has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11916336
    Abstract: An electrical header for use in an electrical connector assembly includes a body for mounting to an object and having an opening formed therethrough for receiving an electrical terminal. The body further defines a plug on a first side thereof for engaging with a mating electrical connector of the assembly. The plug includes a pair of first opposing sidewalls extending from the body at a first height and defining a locking feature for engaging with a corresponding locking feature of the mating connector, and a pair of second opposing sidewalls extending from the body at a second height, less than the first height. The first and second pairs of opposing sidewalls are adapted to mate with a first mating connector oriented in a first direction, and mate with a second mating connector oriented in a second direction distinct from the first direction.
    Type: Grant
    Filed: October 20, 2021
    Date of Patent: February 27, 2024
    Assignee: TE Connectivity Solutions GmbH
    Inventors: Thomas Robert DeWitte, Adam Price Tyler, Lindsey Gatesman, David James Rhein
  • Patent number: 11339178
    Abstract: Compounds and compositions are provided that comprise selective b-glucuronidase inhibitors. The compounds and compositions can ameliorate the side effects of chemotherapeutic agents and can improve the efficacy of such agents, including irinotecan and non-steroidal anti-inflammatory drugs.
    Type: Grant
    Filed: July 20, 2017
    Date of Patent: May 24, 2022
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Matthew R. Redinbo, Jian Jin, Lindsey James, Sam Pellock, Ranathunga Arachchillage Yamuna Ariyarathna, Stephen Frye
  • Publication number: 20190330237
    Abstract: Compounds and compositions are provided that comprise selective b-glucuronidase inhibitors. The compounds and compositions can ameliorate the side effects of chemotherapeutic agents and can improve the efficacy of such agents, including irinotecan and non-steroidal anti-inflammatory drugs.
    Type: Application
    Filed: July 20, 2017
    Publication date: October 31, 2019
    Applicant: The University of North Carolina at Chapel Hill
    Inventors: Matthew R. Redinbo, Jian Jin, Lindsey James, Sam Pellock, Ranathunga Arachchillage Yamu Ariyarathna, Stephen Frye